Increasing maximum tumor dose to manage range uncertainties in IMPT treatment planning

Physics in Medicine and Biology

Volumn 58, Issue 20, 2013, Pages 7329-7341

  Petit, Steven ^a   Seco, Joao ^b   Kooy, Hanne ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOSE REDUCTION; GEOMETRIC MARGIN; INTENSITY MODULATED PROTON THERAPIES; RANGE UNCERTAINTY; ROBUST OPTIMIZATION; TARGET COVERAGE; TREATMENT PLANNING; WORST CASE SCENARIO;

OPTIMIZATION;

TUMORS;

ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; HUMAN; IMAGE QUALITY; INTENSITY MODULATED RADIATION THERAPY; LIVER TUMOR; METHODOLOGY; NEOPLASM; ORGANS AT RISK; RADIATION DOSE; RADIATION EXPOSURE; UNCERTAINTY; LIVER NEOPLASMS; NEOPLASMS; PROCEDURES; RADIATION RESPONSE;

HUMANS; LIVER NEOPLASMS; NEOPLASMS; ORGANS AT RISK; PHANTOMS, IMAGING; RADIATION DOSAGE; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; UNCERTAINTY;

EID: 84885160410     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/58/20/7329     Document Type: Article

References (18)

1. Albertini F, Hug E B and Lomax A J 2011 Is it necessary to plan with safety margins for actively scanned proton therapy? Phys. Med. Biol. 56 4399-413
2. Chen W, Craft D, Madden T M, Zhang K, Kooy H M and Herman G T 2010 A fast optimization algorithm for multicriteria intensity modulated proton therapy planning Med. Phys. 37 4938-45
3. Chen W, Unkelbach J, Trofimov A, Madden T, Kooy H, Bortfeld T and Craft D 2012 Including robustness in multi-criteria optimization for intensity-modulated proton therapy Phys. Med. Biol. 57 591-608
4. Engelsman M, Rietzel E and Kooy H M 2006 Four-dimensional proton treatment planning for lung tumors Int. J. Radiat. Oncol. Biol. Phys. 64 1589-95
5. Fredriksson A, Forsgren A and Hardemark B 2011 Minimax optimization for handling range and setup uncertainties in proton therapy Med. Phys. 38 1672-84
6. Hurkmans C W, Cuijpers J P, Lagerwaard F J, Widder J, van der Heide U A, Schuring D and Senan S 2009 Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the quality assurance working party of the randomised phase III ROSEL study Radiat. Oncol. 4 1
7. ICRU 1999 Prescribing, recording, and reporting photon beam therapy (supplement to ICRU report 50) ICRU Report No. vol 62 (Bethesda, MD: ICRU)
8. Knopf A C, Hong T S and Lomax A 2011 Scanned proton radiotherapy for mobile targets-the effectiveness of re-scanning in the context of different treatment planning approaches and for different motion characteristics Phys. Med. Biol. 56 7257-71
9. Liu W, Zhang X, Li Y and Mohan R 2012 Robust optimization of intensity modulated proton therapy Med. Phys. 39 1079-91
10. Lomax A 1999 Intensity modulation methods for proton radiotherapy Phys. Med. Biol. 44 185-205 (Pubitemid 29062235)
11. Lomax A J 2008 Intensity modulated proton therapy and its sensitivity to treatment uncertainties 2: the potential effects of inter-fraction and inter-field motions Phys. Med. Biol. 53 1043-56 (Pubitemid 351238122)
12. Mendez Romero A et al 2006 Stereotactic body radiation therapy for primary and metastatic liver tumors: a single institution phase i-ii study Acta Oncol. 45 831-7 (Pubitemid 44423129)
13. Paganetti H 2012 Range uncertainties in proton therapy and the role of Monte Carlo simulations Phys. Med. Biol. 57 R99-117
14. Pflugfelder D, Wilkens J J and Oelfke U 2008 Worst case optimization: a method to account for uncertainties in the optimization of intensity modulated proton therapy Phys. Med. Biol. 53 1689-700 (Pubitemid 351423005)
15. Timmerman R D, Galvin J, Gore E, Pass H, Edelman M J and Kong F P 2007 RTOG 0618: A phase II trial of stereotactic body radiation therapy (SBRT) in the treatment of patients with operable stage I/II non-small cell lung cancer (Philadelphia, PA: Radiation Therapy Oncology Group)
16. Unkelbach J, Bortfeld T, Martin B C and Soukup M 2009 Reducing the sensitivity of IMPT treatment plans to setup errors and range uncertainties via probabilistic treatment planning Med. Phys. 36 149-63
17. Urie M, Goitein M and Wagner M 1984 Compensating for heterogeneities in proton radiation therapy Phys. Med. Biol. 29 553-66 (Pubitemid 14054632)
18. Zhang M, Flynn R T, Mo X and Mackie T R 2012 The energy margin strategy for reducing dose variation due to setup uncertainty in intensity modulated proton therapy (IMPT) delivered with distal edge tracking (DET) J. Appl. Clin. Med. Phys. 13 3863